PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LABP vs. SLNO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between LABP and SLNO is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

LABP vs. SLNO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Landos Biopharma, Inc. (LABP) and Soleno Therapeutics, Inc. (SLNO). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February0
-4.08%
LABP
SLNO

Key characteristics

Fundamentals

Market Cap

LABP:

$71.68M

SLNO:

$1.94B

EPS

LABP:

-$4.00

SLNO:

-$2.79

Total Revenue (TTM)

LABP:

$0.00

SLNO:

$0.00

EBITDA (TTM)

LABP:

-$9.30M

SLNO:

-$124.16M

Returns By Period


LABP

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

SLNO

YTD

0.33%

1M

-3.65%

6M

-4.08%

1Y

-13.85%

5Y*

1.59%

10Y*

-20.98%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

LABP vs. SLNO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LABP
The Risk-Adjusted Performance Rank of LABP is 9999
Overall Rank
The Sharpe Ratio Rank of LABP is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of LABP is 9999
Sortino Ratio Rank
The Omega Ratio Rank of LABP is 9999
Omega Ratio Rank
The Calmar Ratio Rank of LABP is 9999
Calmar Ratio Rank
The Martin Ratio Rank of LABP is 100100
Martin Ratio Rank

SLNO
The Risk-Adjusted Performance Rank of SLNO is 3939
Overall Rank
The Sharpe Ratio Rank of SLNO is 3939
Sharpe Ratio Rank
The Sortino Ratio Rank of SLNO is 3838
Sortino Ratio Rank
The Omega Ratio Rank of SLNO is 3737
Omega Ratio Rank
The Calmar Ratio Rank of SLNO is 4242
Calmar Ratio Rank
The Martin Ratio Rank of SLNO is 3737
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LABP vs. SLNO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Landos Biopharma, Inc. (LABP) and Soleno Therapeutics, Inc. (SLNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for LABP, currently valued at 1.52, compared to the broader market-3.00-2.00-1.000.001.002.003.001.52-0.14
The chart of Sortino ratio for LABP, currently valued at 39.19, compared to the broader market-6.00-4.00-2.000.002.004.0039.190.20
The chart of Omega ratio for LABP, currently valued at 13.86, compared to the broader market0.501.001.502.0013.861.02
The chart of Calmar ratio for LABP, currently valued at 2.75, compared to the broader market0.002.004.006.002.75-0.27
The chart of Martin ratio for LABP, currently valued at 429.19, compared to the broader market-10.000.0010.0020.00429.19-0.51
LABP
SLNO


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
1.52
-0.14
LABP
SLNO

Dividends

LABP vs. SLNO - Dividend Comparison

Neither LABP nor SLNO has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

LABP vs. SLNO - Drawdown Comparison


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-85.90%
-23.79%
LABP
SLNO

Volatility

LABP vs. SLNO - Volatility Comparison

The current volatility for Landos Biopharma, Inc. (LABP) is 0.00%, while Soleno Therapeutics, Inc. (SLNO) has a volatility of 10.12%. This indicates that LABP experiences smaller price fluctuations and is considered to be less risky than SLNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February0
10.12%
LABP
SLNO

Financials

LABP vs. SLNO - Financials Comparison

This section allows you to compare key financial metrics between Landos Biopharma, Inc. and Soleno Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab